“…We encountered three cases of primary thyroid carcinoma exhibiting unique microscopic findings that have never been described previously to the best of our knowledge. The patients were adolescents or young 19 (RCK108, 250 dilution, Dako, Glostrup, Denmark), the anti-mitochondria antibody (AMA) (MTC02, 1.5 dilution, NeoMarkers, Fremont, CA, USA), calcitonin (polyclonal, 2 dilution, Dako, Glostrup, Denmark), carcinoembryonic antigen (COL1, 3 dilution, HISTOFINE, Tokyo, Japan), GATA3 (L50-823, 400 dilution, Biocare Medical, Concord, CA, USA), CD10 (56C6, 100 dilution, Novocastra, Newcastle, UK), CD117 (polyclonal, 50 dilution, Dako, Carpinteria, CA, USA), p63 (4A4, 1 dilution, HISTOFINE, Tokyo, Japan), E-cadherin (NCH38, 100 dilution, Glostrup, Denmark), MUC1 (Ma695, 100 dilution, Novocastra, Newcastle, UK), p53 (DO7, 1000 dilution, Dako, Glostrup, Denmark), and Ki-67 (MIB1, 200 dilution, Glostrup, Denmark). The mutational status of the BRAF (exon 15), NRAS, HRAS and KRAS (exons 2 and 3) genes was examined as described previously (case 1 and 2, [6]; case 3, [7]).…”